Bank Pictet & Cie (Europe)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,825
| Closed | -$260K | – | 274 |
|
|
2023
Q3 | $260K | Sell |
6,825
-94
| -1% | -$3.58K | 0.01% | 230 |
|
|
2023
Q2 | $630K | Sell |
6,919
-422
| -6% | -$38.4K | 0.02% | 163 |
|
|
2023
Q1 | $484K | Buy |
7,341
+79
| +1% | +$5.21K | 0.02% | 130 |
|
|
2022
Q4 | $376K | Sell |
7,262
-35
| -0.5% | -$1.81K | 0.02% | 134 |
|
|
2022
Q3 | $498K | Hold |
7,297
| – | – | 0.02% | 120 |
|
|
2022
Q2 | $330K | Sell |
7,297
-1,772
| -20% | -$80.1K | 0.02% | 131 |
|
|
2022
Q1 | $461K | Buy |
9,069
+2,734
| +43% | +$139K | 0.02% | 129 |
|
|
2021
Q4 | $300K | Buy |
+6,335
| New | +$300K | 0.01% | 147 |
|
|
2021
Q3 | – | Sell |
-9,041
| Closed | -$571K | – | 170 |
|
|
2021
Q2 | $571K | Buy |
9,041
+1,160
| +15% | +$73.3K | 0.02% | 132 |
|
|
2021
Q1 | $338K | Buy |
+7,881
| New | +$338K | 0.01% | 148 |
|